FASEB Announces FASEB Cancer, a New Journal Advancing Discovery Across Cancer Science | Newswise
FASEB announces FASEB Cancer, a new interdisciplinary journal advancing research across cancer science. The journal will connect biological discovery with biomedical and translational impact, with a search now underway for its founding Editor-in-Chief.
Newswise — ROCKVILLE, MD (July 15, 2026) — The Federation of American Societies for Experimental Biology (FASEB) is pleased to announce the development ofFASEB Cancer, a new scholarly journal dedicated to advancing impactful research across the biological and biomedical ecosystem of cancer science. Joining the broader FASEB Publications family, which includesThe FASEB JournalandFASEB BioAdvances,FASEB Cancerwill expand FASEB’s commitment to publishing rigorous, community-driven research that advances scientific discovery and improves human health. As cancer research continues to evolve at an unprecedented pace, scientific discovery increasingly depends on collaboration across disciplines—from basic biology to translational research, epidemiology, and clinical investigation. FASEB Canceris being developed to provide a rigorous, interdisciplinary publishing venue for research that deepens our understanding of cancer biology and accelerates progress toward improved prevention, diagnosis, and treatment. “Science doesn’t end when the work is done—it begins when the work is shared. Cancer remains one of the most complex and urgent scientific challenges of our time, and meaningful progress depends on bringing together discovery across disciplines”said Tammy Hanna, PhD, Chief Publishing Officer of FASEB. “FASEB Cancer will provide a rigorous, interdisciplinary home for cancer research within a federation committed to advancing scientific discovery and supporting the researchers shaping the future of cancer science. ”Editor-in-Chief Search UnderwayFASEB has convened an Editor-in-Chief Search Committee to identify the founding editorial leader forFASEB Cancer. The inaugural Editor-in-Chief will play a central role in shaping the journal’s scientific vision, editorial standards, and scope within the cancer research community. FASEB welcomes expressions of interest, nominations, and recommendations from established leaders in cancer research, translational science, and clinical oncology. Researchers interested in learning more about the Editor-in-Chief opportunity or being considered for the role are encouraged tofill out this form indicating interest byAugust 10, 2026. Additional details regarding the journal’s editorial leadership, launch timeline, scope, and submission opportunities will be announced in the coming months. ###About FASEBFASEB is comprised of 21 scientific member societies with 100,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB’s mission is to advance health and well-being by promoting research and education in biological and biomedical sciences through collaborative advocacy and service to member societies and their members. Visitfaseb. orgfor more information. Find FASEB OnlineWebsite:www. faseb. orgX:@FASEBorgand@FASEBPubsLinkedIn:FASEBInstagram:@FASEBofficialBluesky:@faseborg. bsky. social